Development of a porous poly(DL-lactic acid-co-glycolic acid)-based scaffold for mastoid air-cell regeneration

Gould, Toby W.A. and Birchall, John P. and Mallick, Ali S. and Alliston, Tamara and Lustig, Lawrence R. and Shakesheff, Kevin M. and Rahman, Cheryl V. (2013) Development of a porous poly(DL-lactic acid-co-glycolic acid)-based scaffold for mastoid air-cell regeneration. The Laryngoscope., 123 (12). pp. 3156-3161. ISSN 0023-852X

[img] PDF - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
Available under Licence Creative Commons Attribution.
Download (505kB)

Abstract

Objectives/Hypothesis: To develop a porous, biodegradable scaffold for mastoid air-cell regeneration.

Study Design: In vitro development of a temperature-sensitive poly(DL-lactic acid-co-glycolic acid)/poly(ethylene glycol) (PLGA/PEG) scaffold tailored for this application.

Methods: Human mastoid bone microstructure and porosity were investigated using micro-computed tomography.

PLGA/PEG-alginate scaffolds were developed, and scaffold porosity was assessed. Human bone marrow mesenchymal stem

cells (hBM-MSCs) were cultured on the scaffolds in vitro. Scaffolds were loaded with ciprofloxacin, and release of ciprofloxacin over time in vitro was assessed.

Results: Porosity of human mastoid bone was measured at 83% with an average pore size of 1.3 mm. PLGA/PEG-alginate

scaffold porosity ranged from 43% to 78% depending on the alginate bead content. The hBM-MSCs proliferate on the

scaffolds in vitro, and release of ciprofloxacin from the scaffolds was demonstrated over 7 to 10 weeks.

Conclusions: The PLGA/PEG-alginate scaffolds developed in this study demonstrate similar structural features to human mastoid bone, support cell growth, and display sustained antibiotic release. These scaffolds may be of potential clinical use in mastoid air-cell regeneration. Further in vivo studies to assess the suitability of PLGA/PEG-alginate scaffolds for this application are required.

Key Words: Scaffold, poly(DL-lactic acid-co-glycolic acid), alginate, mastoid, ciprofloxacin.

Level of Evidence: N/A.

Item Type: Article
Schools/Departments: University of Nottingham UK Campus > Faculty of Science > School of Pharmacy
Identification Number: https://doi.org/10.1002/lary.24173
Depositing User: de Sousa, Mrs Shona
Date Deposited: 10 Apr 2014 13:26
Last Modified: 15 Sep 2016 12:45
URI: http://eprints.nottingham.ac.uk/id/eprint/2923

Actions (Archive Staff Only)

Edit View Edit View